Impact of HIV-1 Fitness on Disease Progression

HIV-1 健康状况对疾病进展的影响

基本信息

  • 批准号:
    8115894
  • 负责人:
  • 金额:
    $ 37.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-15 至 2012-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): HIV-1 fitness is a complex parameter defined by the adaptability of the virus to a given environment. Over the past four years we have studied the ex vivo fitness of HIV-1 in various primary human cells and have explored possible relationships with disease progression as well as global and temporal evolution of the virus in the human epidemic. In this proposal we will focus on changes in replicative HIV-1 fitness during the natural history of disease and following discrete transmission events in subtype A, C, and D infected patients. Over the past three years, we have analyzed samples from over 266 Zimbabwean and Ugandan women recruited within three months of acute infections and have followed their progression every three months thereafter. This cohort also provides an excellent opportunity to compare the affects of HIV-1 subtype on infection and subsequent disease outcomes. As a lead up to this study, we have published fairly exhaustive comparisons on the fitness of HIV types (1 or 2), groups (M and O), subtype (A through F), and recombinant forms and found the order of ex vivo HIV replicative fitness to be: HIV-1 group M (subtypes A, B, D, F, CRF01_AE, CRF02_AG, CRF012_BF) > subtype C > HIV-2 " HIV-1 group O. Based on preliminary data that shows slower disease progression in subtype C infections and that subtype C virus is intrinsically less fit, our study will address if these two observations are linked and if subtype C represents an attenuated HIV-1 form. These hypotheses will be tested in the following specific aims. Specific aim 1: To establish a rapid yeast-based env cloning system to produce chimeric env viruses. To further examine if ex vivo HIV-1 fitness maps to the env gene and is controlled by the HIV-1 entry process into host cells. Specific aim 2: To explore the relationships between HIV-1 fitness/diversity at acute/early infection Specific aim 3: To examine changes in viral fitness, genetic diversity, and other clinical correlates during disease progression. To relate changes to subtype.
描述(由申请人提供):HIV-1适合性是由病毒对给定环境的适应性定义的一个复杂参数。在过去的四年里,我们研究了HIV-1在各种原代人类细胞中的体外适合性,并探索了与疾病进展以及人类流行病中病毒的全球和时间演变的可能关系。在这项提案中,我们将重点关注在疾病自然病史期间以及在A、C和D亚型感染患者中发生离散传播事件后复制HIV-1适合性的变化。在过去的三年里,我们分析了在急性感染后三个月内招募的266多名津巴布韦和乌干达妇女的样本,并在此之后每三个月跟踪观察她们的进展。这一队列还提供了一个很好的机会来比较艾滋病毒-1亚型对感染和随后的疾病结果的影响。在这项研究之前,我们发表了对HIV类型(1或2)、组(M和O)、亚型(A到F)和重组形式的适合度的相当详尽的比较,并发现体外HIV复制适合度的顺序为:HIV-1组M(亚型A、B、D、F、CRF01_AE、CRF02_AG、CRF012_BF)>亚型C和GT;HIV-2“HIV-1 O组。根据初步数据显示,C亚型感染的疾病进展较慢,C亚型病毒本质上不太适合,我们的研究将讨论这两个观察结果是否有联系,以及C亚型是否代表减弱的HIV-1形式。这些假设将在以下具体目标中得到检验。具体目的1:建立一种基于酵母的包膜病毒快速克隆系统,以生产嵌合包膜病毒。为了进一步检查体外HIV-1适合度是否映射到env基因,并受HIV-1进入宿主细胞的过程控制。具体目标2:探讨HIV-1在急性/早期感染时适应性/多样性之间的关系。具体目标3:检查病毒适应性、遗传多样性和其他临床相关性在疾病进展过程中的变化。若要将更改关联到子类型,请执行以下操作。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERIC J ARTS其他文献

ERIC J ARTS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERIC J ARTS', 18)}}的其他基金

Ugandan Laboratory Core
乌干达实验室核心
  • 批准号:
    7930068
  • 财政年份:
    2010
  • 资助金额:
    $ 37.14万
  • 项目类别:
Consequences of immune escape on viral fitness
免疫逃逸对病毒适应性的影响
  • 批准号:
    7854611
  • 财政年份:
    2010
  • 资助金额:
    $ 37.14万
  • 项目类别:
Ugandan Laboratory
乌干达实验室
  • 批准号:
    7933416
  • 财政年份:
    2009
  • 资助金额:
    $ 37.14万
  • 项目类别:
New SHIV R5 env's (based on all subtypes) for effective microbicide testing in ma
新的 SHIV R5 env(基于所有亚型)可在马进行有效的杀菌剂测试
  • 批准号:
    7536240
  • 财政年份:
    2008
  • 资助金额:
    $ 37.14万
  • 项目类别:
New SHIV R5 env's (based on all subtypes) for effective microbicide testing in ma
新的 SHIV R5 env(基于所有亚型)可在马进行有效的杀菌剂测试
  • 批准号:
    7690343
  • 财政年份:
    2008
  • 资助金额:
    $ 37.14万
  • 项目类别:
Impact of HIV-1 Fitness on Disease Progression
HIV-1 健康状况对疾病进展的影响
  • 批准号:
    7340958
  • 财政年份:
    2007
  • 资助金额:
    $ 37.14万
  • 项目类别:
Impact of HIV-1 Fitness on Disease Progression
HIV-1 健康状况对疾病进展的影响
  • 批准号:
    7679613
  • 财政年份:
    2007
  • 资助金额:
    $ 37.14万
  • 项目类别:
Impact of HIV-1 Fitness on Disease Progression
HIV-1 健康状况对疾病进展的影响
  • 批准号:
    8051212
  • 财政年份:
    2007
  • 资助金额:
    $ 37.14万
  • 项目类别:
Impact of HIV-1 Fitness on Disease Progression
HIV-1 健康状况对疾病进展的影响
  • 批准号:
    7484266
  • 财政年份:
    2007
  • 资助金额:
    $ 37.14万
  • 项目类别:
Impact of HIV-1 Fitness on Disease Progression
HIV-1 健康状况对疾病进展的影响
  • 批准号:
    7920891
  • 财政年份:
    2007
  • 资助金额:
    $ 37.14万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了